(a)Two doses, at least 1 month apart, recommended in HIV-infected individuals non-immune to measles and a CD4 count ≥ 200/mm3(b)Recommended in HIV-positive non-pregnant women of child-bearing age who are Rubella seronegative and have a CD4 count > 200 cells/mm3. This evidence concerns the gene CD4 and rubella.